## Note
nid: 1550333589889
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step1_v11::#OME_banner, #AK_Step2_v11::!FLAG_THESE_CARDS::Potential_duplicates, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::6im, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::!Shelf::IM::no_dupes::only_step2, #AK_Step2_v11::#B&B::01_Cardiology::Other::Perph_Vascular_Diseases, #AK_Step2_v11::#Resources_by_rotation::IM::uw::cardio::cardio_zanki, #AK_Step2_v11::#Subjects::Cardiology::12_Vascular_Pathology::Peripheral_Vascular_Pathology::CCB_Peripheral_Edema, #AK_Step2_v11::#UWorld::10000-99999::10000-10999::10179, #AK_Step2_v11::Original_decks::Zanki_Step_2::IM::Cardio
markdown: false

### Text
<div>
  What <b>antihypertensive</b> can be used to <u>prevent calcium
  channel blocker-induced peripheral edema</u>?
</div>
<div>
  {{c1::ACE inhibitors or ARBs}}
</div>

### Extra
<div>
  <b>CCBs</b> causes more <b>precapillary</b> <u>arteriolar</u>
  dilation → ↑ hydrostatic pressure, while ACE inhibitors cause
  <b>postcapillary</b> <u>venodilation</u> (↓ hydrostatic
  pressure).
</div>
<div>
  __
</div>
<div>
  Peripheral edema is a common side effect of calcium channel
  blocker (CCB) therapy, with a reported incidence of approximately
  25% after 6 months of therapy. The edema is likely related to
  preferential dilation of precapillary vessels (arteriolar
  dilation), which leads to increased capillary hydrostatic
  pressure and fluid extravasation into the interstitium.
  Dihydropyridine (DHP) CCBs such as amlodipine and nifedipine are
  potent arteriolar dilators and cause more peripheral edema than
  non-dihydropyridine CCBs (e.g. diltiazem, verapamil). Other major
  side effects associated with DHP CCBs include headache, flushing,
  and dizziness.
</div>
<div>
  Renin-angiotensin system antagonists (angiotensin-converting
  enzyme [ACE] inhibitors or angiotensin receptor blockers [ARBs])
  cause post-capillary venodilation and can normalize the increased
  capillary hydrostatic pressure. In clinical studies, the
  combination of CCB and ACE inhibitors was associated with a
  significantly lower risk of CCB-associated peripheral edema
  compared with CCB monotherapy.
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

